3/9
04:35 pm
rcus
Arcus Biosciences Announces New Employment Inducement Grants
Medium
Report
Arcus Biosciences Announces New Employment Inducement Grants
3/5
02:48 pm
rcus
Arcus Biosciences (RCUS) had its price target raised by Citigroup Inc. from $44.00 to $45.00. They now have a "buy" rating on the stock.
Low
Report
Arcus Biosciences (RCUS) had its price target raised by Citigroup Inc. from $44.00 to $45.00. They now have a "buy" rating on the stock.
3/2
03:28 pm
rcus
Arcus Biosciences (RCUS) had its price target raised by Leerink Partners from $36.00 to $49.00. They now have an "outperform" rating on the stock.
Low
Report
Arcus Biosciences (RCUS) had its price target raised by Leerink Partners from $36.00 to $49.00. They now have an "outperform" rating on the stock.
3/2
08:03 am
rcus
Arcus Biosciences (RCUS) had its "buy" rating reaffirmed by HC Wainwright. They now have a $32.00 price target on the stock.
High
Report
Arcus Biosciences (RCUS) had its "buy" rating reaffirmed by HC Wainwright. They now have a $32.00 price target on the stock.
3/2
07:35 am
rcus
Arcus Biosciences Puts Casdatifan Kidney Cancer Data At Center Stage [Yahoo! Finance]
High
Report
Arcus Biosciences Puts Casdatifan Kidney Cancer Data At Center Stage [Yahoo! Finance]
2/28
05:15 pm
rcus
Arcus Biosciences Q4 Earnings Call Highlights [Yahoo! Finance]
High
Report
Arcus Biosciences Q4 Earnings Call Highlights [Yahoo! Finance]
2/26
04:05 pm
rcus
Arcus Biosciences to Participate in Two Upcoming Investor Conferences
Medium
Report
Arcus Biosciences to Participate in Two Upcoming Investor Conferences
2/25
11:26 pm
rcus
Arcus Biosciences, Inc. (RCUS) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Arcus Biosciences, Inc. (RCUS) Q4 2025 Earnings Call Transcript [Seeking Alpha]
2/25
07:26 pm
rcus
Arcus (RCUS) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Arcus (RCUS) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
2/25
04:27 pm
rcus
Arcus Biosciences Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides a Pipeline Update [Yahoo! Finance]
Medium
Report
Arcus Biosciences Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides a Pipeline Update [Yahoo! Finance]
2/25
04:05 pm
rcus
Arcus Biosciences Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides a Pipeline Update
Medium
Report
Arcus Biosciences Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides a Pipeline Update
2/23
05:00 pm
rcus
Arcus Presents New Data for its HIF-2a Inhibitor Casdatifan, Which Showed Progression-Free Survival Beyond One Year in Late-Line Kidney Cancer
Medium
Report
Arcus Presents New Data for its HIF-2a Inhibitor Casdatifan, Which Showed Progression-Free Survival Beyond One Year in Late-Line Kidney Cancer
2/15
11:53 pm
rcus
A Look At Arcus Biosciences (RCUS) Valuation After Wells Fargo Downgrade And Shifting Analyst Sentiment [Yahoo! Finance]
Low
Report
A Look At Arcus Biosciences (RCUS) Valuation After Wells Fargo Downgrade And Shifting Analyst Sentiment [Yahoo! Finance]
2/13
06:29 am
rcus
Arcus Biosciences (NYSE:RCUS) was downgraded by analysts at Wells Fargo & Company from a "strong-buy" rating to a "hold" rating.
Medium
Report
Arcus Biosciences (NYSE:RCUS) was downgraded by analysts at Wells Fargo & Company from a "strong-buy" rating to a "hold" rating.
2/12
07:17 am
rcus
Arcus Biosciences (NYSE:RCUS) was given a new $23.00 price target on by analysts at Wells Fargo & Company.
Medium
Report
Arcus Biosciences (NYSE:RCUS) was given a new $23.00 price target on by analysts at Wells Fargo & Company.
2/11
04:29 pm
rcus
Arcus Biosciences to Host Conference Call to Discuss Fourth-Quarter and Full-Year 2025 Financial Results and Pipeline Updates [Yahoo! Finance]
Medium
Report
Arcus Biosciences to Host Conference Call to Discuss Fourth-Quarter and Full-Year 2025 Financial Results and Pipeline Updates [Yahoo! Finance]
2/11
04:05 pm
rcus
Arcus Biosciences to Host Conference Call to Discuss Fourth-Quarter and Full-Year 2025 Financial Results and Pipeline Updates
Medium
Report
Arcus Biosciences to Host Conference Call to Discuss Fourth-Quarter and Full-Year 2025 Financial Results and Pipeline Updates
2/2
06:00 pm
rcus
TIGIT Inhibitors Market Poised for Strong Growth Through 2034, Driven by Expanding Immuno-Oncology Pipeline | DelveInsight [Yahoo! Finance]
Low
Report
TIGIT Inhibitors Market Poised for Strong Growth Through 2034, Driven by Expanding Immuno-Oncology Pipeline | DelveInsight [Yahoo! Finance]
1/26
04:35 pm
rcus
Arcus Biosciences Announces New Employment Inducement Grants
Low
Report
Arcus Biosciences Announces New Employment Inducement Grants
1/23
05:06 am
rcus
Arcus Biosciences (NYSE:RCUS) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Arcus Biosciences (NYSE:RCUS) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
1/18
01:00 am
rcus
Arcus Biosciences (NYSE:RCUS) was upgraded by analysts at
Wall Street Ze
Low
Report
Arcus Biosciences (NYSE:RCUS) was upgraded by analysts at
Wall Street Ze
1/12
05:02 pm
rcus
Arcus Biosciences (NYSE:RCUS) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating.
Medium
Report
Arcus Biosciences (NYSE:RCUS) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating.
1/10
01:07 am
rcus
Arcus Biosciences (NYSE:RCUS) was downgraded by analysts at
Wall Street
Low
Report
Arcus Biosciences (NYSE:RCUS) was downgraded by analysts at
Wall Street
1/8
07:09 am
rcus
Arcus Biosciences (NYSE:RCUS) was given a new $20.00 price target on by analysts at Morgan Stanley.
Medium
Report
Arcus Biosciences (NYSE:RCUS) was given a new $20.00 price target on by analysts at Morgan Stanley.
1/7
04:23 pm
rcus
Arcus Outlines 2026 Plans for Casdatifan, its Potential Best-in-Class HIF-2a Inhibitor, and its Inflammation Programs [Yahoo! Finance]
Medium
Report
Arcus Outlines 2026 Plans for Casdatifan, its Potential Best-in-Class HIF-2a Inhibitor, and its Inflammation Programs [Yahoo! Finance]